BlackRock, Inc. 13D and 13G filings for Kezar Life Sciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-07-08 4:32 pm Sale | 2024-06-30 | 13G | Kezar Life Sciences, Inc. KZR | BlackRock Inc. BLK | 83,037 1.100% | -398,690 (-82.76%) | Filing |
| 2024-01-29 3:26 pm Purchase | 2023-12-31 | 13G | Kezar Life Sciences, Inc. KZR | BlackRock Inc. BLK | 481,727 6.600% | 58,635 (+13.86%) | Filing |
| 2023-02-03 4:27 pm Purchase | 2022-12-31 | 13G | Kezar Life Sciences, Inc. KZR | BlackRock Inc. BLK | 423,091 6.200% | 135,967 (+47.35%) | Filing |
| 2022-05-09 3:23 pm Purchase | 2022-04-30 | 13G | Kezar Life Sciences, Inc. KZR | BlackRock Inc. BLK | 287,124 4.800% | 18,422 (+6.86%) | Filing |
| 2022-02-03 4:41 pm Purchase | 2021-12-31 | 13G | Kezar Life Sciences, Inc. KZR | BlackRock Inc. BLK | 268,702 5.500% | 16,793 (+6.67%) | Filing |
| 2021-02-02 2:56 pm Purchase | 2020-12-31 | 13G | Kezar Life Sciences, Inc. KZR | BlackRock Inc. BLK | 251,909 5.400% | 251,909 (New Position) | Filing |